
### [NCIT:C3107](http://purl.obolibrary.org/obo/NCIT_C3107)
**Label:** Langerhans Cell Histiocytosis

**Subclasses:** [NCIT:C129806](http://purl.obolibrary.org/obo/NCIT_C129806) (Central Nervous System Langerhans Cell Histiocytosis), [NCIT:C3016](http://purl.obolibrary.org/obo/NCIT_C3016) (Eosinophilic Granuloma), [NCIT:C134177](http://purl.obolibrary.org/obo/NCIT_C134177) (Refractory Langerhans Cell Histiocytosis), [NCIT:C6920](http://purl.obolibrary.org/obo/NCIT_C6920) (Hand-Schuller-Christian Disease), [NCIT:C123395](http://purl.obolibrary.org/obo/NCIT_C123395) (Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement), [NCIT:C114483](http://purl.obolibrary.org/obo/NCIT_C114483) (Childhood Langerhans Cell Histiocytosis), [NCIT:C3160](http://purl.obolibrary.org/obo/NCIT_C3160) (Letterer-Siwe Disease), [NCIT:C114929](http://purl.obolibrary.org/obo/NCIT_C114929) (Adult Langerhans Cell Histiocytosis), [NCIT:C123396](http://purl.obolibrary.org/obo/NCIT_C123396) (Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement), [NCIT:C134175](http://purl.obolibrary.org/obo/NCIT_C134175) (Recurrent Langerhans Cell Histiocytosis), 

**Class expressions from DL-Learner:**

- Thing 54.23%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C39620](http://purl.obolibrary.org/obo/NCIT_C39620) (Dermatopathic Lymphadenopathy))) 51.85%
- [NCIT:C3367](http://purl.obolibrary.org/obo/NCIT_C3367) (Finding) 51.12%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 51.09%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) 37.21%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C39802](http://purl.obolibrary.org/obo/NCIT_C39802) (Renal Cell Carcinoma Associated with inv(X)(p11;q12)))) 37.21%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C39801](http://purl.obolibrary.org/obo/NCIT_C39801) (inv(X)(p11;q12)))) 37.21%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C39800](http://purl.obolibrary.org/obo/NCIT_C39800) (Sickle Cell Trait))) 37.21%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C39799](http://purl.obolibrary.org/obo/NCIT_C39799) (Loss of Chromosome 21))) 37.21%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C39798](http://purl.obolibrary.org/obo/NCIT_C39798) (Loss of Chromosome 2))) 37.21%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C39795](http://purl.obolibrary.org/obo/NCIT_C39795) (Loss of Chromosome 14q))) 37.21%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C39788](http://purl.obolibrary.org/obo/NCIT_C39788) (MET Gene Mutation))) 37.21%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C39787](http://purl.obolibrary.org/obo/NCIT_C39787) (Multiple Tumor Masses))) 37.21%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C39786](http://purl.obolibrary.org/obo/NCIT_C39786) (Bilateral Disease))) 37.21%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C39783](http://purl.obolibrary.org/obo/NCIT_C39783) (Retinal Hemangioblastoma))) 37.21%


